Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRAGet Free Report) have been given an average recommendation of “Moderate Buy” by the nine analysts that are currently covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $19.25.

Several brokerages recently commented on SBRA. Mizuho reissued a “neutral” rating and issued a $20.00 price objective on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. Scotiabank increased their price target on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a research note on Friday, October 11th. Wells Fargo & Company raised Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $16.00 to $20.00 in a report on Tuesday, October 1st. Citizens Jmp upgraded Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 7th. Finally, JMP Securities upgraded Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price target on the stock in a report on Tuesday, January 7th.

Read Our Latest Report on Sabra Health Care REIT

Sabra Health Care REIT Trading Down 3.4 %

Shares of SBRA stock opened at $16.59 on Wednesday. Sabra Health Care REIT has a fifty-two week low of $12.83 and a fifty-two week high of $20.03. The stock’s fifty day moving average price is $17.92 and its two-hundred day moving average price is $17.48. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.16 and a current ratio of 4.16. The company has a market cap of $3.92 billion, a PE ratio of 40.46, a P/E/G ratio of 2.20 and a beta of 1.26.

Sabra Health Care REIT (NASDAQ:SBRAGet Free Report) last released its earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.22). The business had revenue of $178.00 million during the quarter, compared to the consensus estimate of $177.19 million. Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. During the same quarter in the prior year, the firm earned $0.34 EPS. Equities analysts predict that Sabra Health Care REIT will post 1.39 EPS for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 29th. Stockholders of record on Friday, November 15th were given a $0.30 dividend. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 7.23%. Sabra Health Care REIT’s dividend payout ratio (DPR) is currently 292.68%.

Institutional Investors Weigh In On Sabra Health Care REIT

Large investors have recently modified their holdings of the company. ORG Partners LLC grew its holdings in Sabra Health Care REIT by 2,031.8% during the 4th quarter. ORG Partners LLC now owns 25,283 shares of the real estate investment trust’s stock worth $438,000 after acquiring an additional 24,097 shares during the period. JPMorgan Chase & Co. boosted its position in shares of Sabra Health Care REIT by 222.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust’s stock valued at $183,996,000 after purchasing an additional 6,819,919 shares in the last quarter. Franklin Resources Inc. grew its stake in Sabra Health Care REIT by 12.3% during the third quarter. Franklin Resources Inc. now owns 524,917 shares of the real estate investment trust’s stock worth $9,543,000 after purchasing an additional 57,551 shares during the period. Wilmington Savings Fund Society FSB bought a new stake in Sabra Health Care REIT in the third quarter worth approximately $59,000. Finally, Geode Capital Management LLC lifted its stake in Sabra Health Care REIT by 1.7% in the third quarter. Geode Capital Management LLC now owns 6,294,798 shares of the real estate investment trust’s stock valued at $117,165,000 after buying an additional 104,533 shares during the period. 99.40% of the stock is currently owned by institutional investors and hedge funds.

About Sabra Health Care REIT

(Get Free Report

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.

Further Reading

Analyst Recommendations for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.